Background: AKI affects 10%–25% of hospitalized patients and is associated with significant morbidity, mortality, and long-term adverse outcomes. Recovery patterns vary greatly, from full reversal to progression toward chronic kidney disease. Predicting short-term AKI states and understanding their dynamic trajectories could help optimize clinical interventions. Methods: This retrospective study used data from four healthcare systems in the Greater Plains Collaborative, spanning 2009–2022. A total of 94,531 inpatient encounters (54% male, 80% White patients) from 75,312 adults with admission eGFR ≥15 mL/min/1.73 m 2 and without prior dialysis or kidney failure were included. We developed CatBoost models, a gradient-boosting decision-tree algorithm, to predict 7-day AKI progression and reversal, then performed multistate modeling to estimate transition intensities and covariate effects on AKI state changes. Results: The models achieved strong performance across outcomes and subgroups: AUROC 0.79–0.89 and accuracy 0.7–0.79 for reversal; AUROC 0.91–0.93 and accuracy 0.83–0.87 for progression. Serum creatinine, systolic blood pressure (SBP), and albumin were key predictors across both outcomes. Low SBP (≤120 mmHg) predicted increased likelihood of progression, whereas high SBP (≥140 mmHg) predicted faster but asymmetric recovery with reduced chances of subsequent reversal. Multi-state analysis highlighted the dynamic and transient nature of AKI recovery, with nearly half of AKI-1 patients (instantaneous hazard rate=0.46) transitioning to “no AKI” peaking on the first day post-onset. Conclusions: This study presents a two-stage analytical framework linking short-term prediction with multi-state modelling to characterize early recovery and progression patterns after hospital-acquired AKI. The approach highlights a small set of routinely measured variables, such as serum creatinine trajectories and blood-pressure trends, that consistently track these dynamics across health systems. While the results are hypothesis-generating and require external, prospective validation, they lay groundwork for future studies on refining risk stratification and exploring targeted interventions in AKI care.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: